Results 61 to 70 of about 21,660 (161)
Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors. [PDF]
Purpose:To evaluate the safety, recommended phase II dose (RP2D) and efficacy of pexidartinib, a colony stimulating factor receptor 1 (CSF-1R) inhibitor, in combination with weekly paclitaxel in patients with advanced solid tumors.
Coussens, Lisa M+12 more
core
Fosfaattiaineenvaihdunnan säätely ja häiriöt [PDF]
•Laboratoriossa mitattu plasman fosfori kuvaa pääosin fosfaattia. Kliinisessä työssä termejä ”fosfori” ja ”fosfaatti” käytetään usein synonyymeinä. •Plasman fosfaatti heijastaa huonosti koko kehon fosfaattivarastoja.
Koistinen, Heikki, Miettinen, Helena
core
Genetic diseases resulting from disordered FGF23/klotho biology [PDF]
Econs, Michael J.
core +1 more source
Severe Unexplained Hypophosphatemia [PDF]
James A Young+2 more
openaire +2 more sources
The Prevalence of Hypophosphatemia and its Associated Risk Factors in Diabetic Ketoacidosis Patients. [PDF]
Razali MHB+3 more
europepmc +1 more source
Severe Hypophosphatemia Leading to Acute Worsening of Heart Failure and Myopathy: A Case Report. [PDF]
Ishikawa Y+3 more
europepmc +1 more source
Case Report: Phosphaturic mesenchymal tumor presenting solely as knee pain without hypophosphatemia. [PDF]
Cao Q, Cheng C, Dai Z.
europepmc +1 more source
Prognostic Significance of Hypophosphatemia in Kidney Transplant Patients: A Systematic Review and Meta-Analysis. [PDF]
Charoenngam N+7 more
europepmc +1 more source